Anticipated deadlines for this opportunity have shifted later, giving you until February 2027 to submit your Letter of Intent and April 2027 for full applications. If your project involves patient recruitment, you can now fulfill the clinical collaboration requirement by partnering with either a physician or an experienced neuropsychologist. Additionally, validation awards now explicitly note that there is no strict funding cap for large-scale studies.
Funder: Alzheimer's Drug Discovery Foundation
Due Dates (Anticipated): February 2027 (Letter of Intent) | April 2027 (Full application)
Funding Amounts: Exploratory: up to ~$250,000; Proof-of-principle: up to ~$500,000; Validation: higher, based on scope—no strict cap; durations vary by project stage.
Summary: Supports development, validation, and translation of digital platforms (wearables, apps, sensors) for Alzheimer's disease detection and monitoring.
Key Information: Clinical collaboration required; both academic and for-profit applicants worldwide eligible; data sharing via Sage Bionetworks expected.